Lukas Milas
#135,960
Most Influential Person Now
Lukas Milas's AcademicInfluence.com Rankings
Lukas Milasbiology Degrees
Biology
#9330
World Rank
#12522
Historical Rank
Biotechnology
#126
World Rank
#128
Historical Rank
Molecular Biology
#1264
World Rank
#1291
Historical Rank
Biochemistry
#1415
World Rank
#1539
Historical Rank
Download Badge
Biology
Why Is Lukas Milas Influential?
(Suggest an Edit or Addition)Lukas Milas's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. (2002) (1190)
- In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. (2000) (531)
- Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein Kinase* (2005) (513)
- Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. (1999) (365)
- Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. (1998) (353)
- Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. (1996) (305)
- The epidermal growth factor receptor mediates radioresistance. (2003) (299)
- Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. (2000) (287)
- Sensitization of breast cancer cells to radiation by trastuzumab. (2003) (252)
- Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. (1979) (235)
- Enhancement of Tumor Response to γ-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme (1999) (228)
- Apoptosis in irradiated murine tumors. (1991) (218)
- Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? (2001) (213)
- Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. (1993) (212)
- Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. (2000) (204)
- Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance? (2003) (185)
- Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. (1974) (181)
- Enhancement of tumor radioresponse in vivo by gemcitabine. (1999) (178)
- Tissue tolerance to reirradiation. (2000) (173)
- Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. (2004) (166)
- Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies. (2004) (166)
- Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. (2009) (160)
- Antitumor activity of Corynebacterium parvum. (1978) (160)
- Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. (1995) (160)
- C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. (2001) (153)
- Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy. (2005) (152)
- CpG Oligodeoxynucleotide Enhances Tumor Response to Radiation (2004) (150)
- Docetaxel enhances tumor radioresponse in vivo. (1997) (150)
- Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. (1994) (147)
- Combination of taxanes with radiation: preclinical studies. (1999) (141)
- Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. (2004) (134)
- Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors. (1999) (131)
- Development of apoptosis in irradiated murine tumors as a function of time and dose. (1993) (131)
- Increase in radioresponse of murine tumors by treatment with indomethacin. (1988) (126)
- Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy. (2003) (125)
- Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. (1987) (121)
- The proportion of stem cells in murine tumors. (1989) (121)
- Apoptosis in murine tumors treated with chemotherapy agents. (1995) (120)
- Maximizing therapeutic gain with gemcitabine and fractionated radiation. (1999) (112)
- Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy. (2000) (109)
- Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol (1995) (106)
- Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. (1988) (105)
- Receptor signaling as a regulatory mechanism of DNA repair. (2009) (105)
- Chemoradiotherapy: Emerging treatment improvement strategies (2003) (104)
- Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse. (2001) (103)
- Influence of preirradiation of lung on development of artificial pulmonary metastases of fibrosarcoma in mice. (1973) (102)
- Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. (1982) (97)
- In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations. (2002) (93)
- Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors. (2004) (90)
- Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. (1984) (88)
- Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results. (2002) (87)
- Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel (1999) (86)
- A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer (2005) (84)
- Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. (1999) (84)
- Cancer invasion and metastasis: biologic and therapeutic aspects. The University of Texas M.D. Anderson Hospital and Tumor Institute. 36th annual symposium on fundamental cancer research. (1983) (83)
- Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo. (1999) (82)
- Interlaboratory variation in oxygen tension measurement by Eppendorf “Histograph” and comparison with hypoxic marker (1997) (82)
- Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrug (1996) (80)
- Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence. (1990) (79)
- Early Detection of Chemoradioresponse in Esophageal Carcinoma by 3′-Deoxy-3′-3H-Fluorothymidine Using Preclinical Tumor Models (2006) (79)
- Potential methods for predicting tumor radiocurability. (1986) (78)
- Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism. (2008) (76)
- Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro (2011) (76)
- Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay. (1985) (74)
- Chemo-radiotherapy: radiosensitizing nucleoside analogues (review). (1999) (73)
- Heterogeneous response and clonal drift of sensitivities of metastatic 13762NF mammary adenocarcinoma clones to gamma-radiation in vitro. (1983) (73)
- Paclitaxel Poliglumex (PPX-Xyotax) and Concurrent Radiation for Esophageal and Gastric Cancer: A Phase I Study (2006) (73)
- Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer (2001) (72)
- Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy. (2007) (71)
- Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells. (2003) (71)
- Cancer stem cells and tumor response to therapy: current problems and future prospects. (2009) (70)
- Anti‐tumor effects of tumor necrosis factor alone or combined with radiotherapy (1988) (70)
- Conjugation of Camptothecins to Poly‐(l‐Glutamic Acid) (2000) (67)
- MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation (2012) (67)
- Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib. (2005) (65)
- Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. (2010) (65)
- Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer. (2004) (64)
- Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas. (2002) (63)
- Protection of acute and late radiation damage of the gastrointestinal tract by WR-2721. (1986) (62)
- Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa. (1995) (62)
- Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index. (2001) (61)
- The effect of tumor size on necrosis and polarographically measured pO2. (1997) (61)
- Eicosanoids and radiation. (1995) (61)
- Enhancement of tumor radioresponse by docetaxel: Involvement of immune system. (2001) (60)
- Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase. (2004) (60)
- Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation. (2007) (60)
- Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. Granulosum and C. Parvum (1974) (59)
- The role of apoptosis in radiation oncology (2009) (59)
- Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse. (1995) (58)
- Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways. (2012) (57)
- 130-nm Albumin–Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain (2007) (57)
- A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe (2011) (56)
- Targeting molecular determinants of tumor chemo-radioresistance. (2005) (55)
- Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability. (2002) (55)
- Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo. (1997) (55)
- Combination of Local Irradiation with Systemic Application of Anaerobic Corynebacteria in Therapy of a Murine Fibrosarcoma (1975) (54)
- CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors. (2006) (54)
- Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process. (2002) (53)
- Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type. (1986) (53)
- Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas. (1988) (53)
- Corynebacterium granulosum-induced Protection against Artificial Pulmonary Metastases of a Syngeneic Fibrosarcoma in Mice (1974) (52)
- Are cancer stem cells radioresistant? (2010) (52)
- Programmed cell death and radioresistance (1996) (51)
- The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo. (1994) (50)
- Relation of apoptosis to cancer therapy. (1994) (49)
- Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide. (1994) (49)
- C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy. (2003) (49)
- Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases. (2003) (48)
- Relationship between lymph nodal status and primary tumor control probability in tumors of the supraglottic larynx. (1985) (48)
- The tumor bed effect: dependence of tumor take, growth rate, and metastasis on the time interval between irradiation and tumor cell transplantation. (1987) (48)
- Effect of tumor type, size, and endpoint on tumor radioprotection by WR-2721. (1984) (47)
- Radiation-induced apoptosis in a murine lymphoma in vivo. (1994) (47)
- Biochemical modulation of radiation-induced apoptosis in murine lymphoma cells. (1993) (47)
- COX-2 Inhibitors as Radiosensitizing Agents for Cancer Therapy (2003) (47)
- Antimutagenic effects of amifostine: clinical implications. (1996) (46)
- Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases. (2006) (45)
- Induction of apoptosis in murine tumors by cyclophosphamide (2004) (44)
- Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. (2007) (44)
- Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism. (1996) (43)
- Radioprotection of cultured mammalian cells by the aminothiols WR-1065 and WR-255591: correlation between protection against DNA double-strand breaks and cell killing after gamma radiation. (1989) (43)
- Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum. (1975) (43)
- Initial Experience Combining Cyclooxygenase-2 Inhibition with Chemoradiation for Locally Advanced Pancreatic Cancer (2003) (43)
- Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer. (2002) (42)
- The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity. (1977) (42)
- Radioprotection of hematopoietic tissues in mice by indomethacin. (1990) (41)
- Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiation. (1984) (41)
- Reemergence of apoptotic cells between fractionated doses in irradiated murine tumors. (1994) (40)
- Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction. (1997) (40)
- INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin (2008) (40)
- Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma. (1996) (39)
- Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme. (2003) (39)
- Modification of radiation responses of murine tumors by misonidazole (Ro 07-0582), host immune capability, and Corynebacterium parvum. (1978) (38)
- Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer. (2007) (38)
- Cyclo-Oxygenase-2 and its Inhibition in Cancer (2012) (37)
- Treatment of experimental lung metastasis with local thoracic irradiation followed by systemic macrophage activation with liposomes containing muramyl tripeptide. (1986) (37)
- Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells. (2011) (37)
- Modification of Radiosensitivity in Cancer Treatment (1985) (36)
- COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer (2004) (36)
- Radioprotective action of WR-1065 on radiation-induced DNA strand breaks in cultured Chinese hamster ovary cells. (1988) (35)
- Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting. (2006) (35)
- Conditioning of tissues for metastasis formation by radiation and cytotoxic drugs. (1983) (35)
- Protection by corynebacterium granulosum against radiation-induced enhancement of artificial pulmonary metastases of a murine fibrosarcoma. (1974) (35)
- Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers. (2011) (35)
- Epidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings (2003) (33)
- S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU. (2006) (33)
- Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice. (1975) (33)
- An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice. (1991) (33)
- The effect of splenectomy on fibrosarcoma “metastases” in lungs of mice (1973) (33)
- Changes in TCD50 as a measure of clonogen doubling time in irradiated and unirradiated tumors. (1991) (33)
- Cyclooxygenase-2 (COX-2) Enzyme Inhibitors and Radiotherapy: Preclinical Basis (2003) (32)
- Metastatic properties of murine sarcomas and carcinomas I. Positive correlation with lung colonization and lack of correlation with s.c. tumor take (1985) (32)
- Spontaneous metastasis: random or selective? (1983) (31)
- Protective effects of WR-2721 against radiation-induced injury of murine gut, testis, lung, and lung tumor nodules. (1982) (30)
- Radioprotectors in tumor radiotherapy: factors and settings determining therapeutic ratio. (1988) (30)
- Biology-based combined-modality radiotherapy: workshop report. (2001) (30)
- Comparative effect of the thiols dithiothreitol, cysteamine and WR-151326 on survival and on the induction of DNA damage in cultured Chinese hamster ovary cells exposed to gamma-radiation. (1990) (30)
- Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer. (2004) (30)
- Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine. (1994) (29)
- Stimulated granulocytopoiesis in mice bearing fibrosarcoma. (1972) (28)
- Combination of radiotherapy with EGFR antagonists for head and neck carcinoma (2007) (28)
- Is tumor cell radiation resistance correlated with metastatic ability? (1994) (28)
- Cytotoxic effects of WR-2721 on mouse testicular cells. (1984) (28)
- Complete regressions of an established murine fibrosarcoma induced by systemic application of Corynebacterium granulosum. (1974) (28)
- Modification of tumor response to cyclophosphamide and irradiation by preirradiation of the tumor bed: prolonged growth delay but reduced curability. (1985) (28)
- Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate. (2000) (28)
- Destruction of hamster ovarian cell cultures by peritoneal macrophages from mice treated with Corynebacterium granulosum. (1974) (28)
- Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors. (1990) (27)
- Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion. (2002) (27)
- Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiation. (1994) (26)
- Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin. (1992) (26)
- Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma. (1999) (26)
- Tumor bed effect-induced reduction of tumor radiocurability through the increase in hypoxic cell fraction. (1989) (26)
- In vivo radioprotective activities of diethyldithiocarbamate (DDC). (1984) (25)
- Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors. (1997) (25)
- Noncovalent assembly of targeted carbon nanovectors enables synergistic drug and radiation cancer therapy in vivo. (2012) (25)
- Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse. (2003) (25)
- Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation-induced leg contractures in mice. (1983) (25)
- Combination of a COX-2 Inhibitor With Radiotherapy or Radiochemotherapy in the Treatment of Thoracic Cancer (2003) (25)
- Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib. (2013) (24)
- Selective Radioprotection of Normal Tissues by Bowman-Birk Proteinase Inhibitor (BBI) in Mice (2005) (24)
- In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum. (1975) (24)
- Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress? (2004) (23)
- Tumor bed effect in murine tumors: relationship to tumor take and tumor macrophage content. (1990) (23)
- AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo (2011) (22)
- Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors. (1982) (22)
- Inhibition of spontaneous metastases formation by amifostine (2002) (22)
- Buoyant density separation of human blood cells in renografin gradients. (1973) (22)
- The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury. (1995) (22)
- Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases (1990) (22)
- Separation of cells from a fibrosarcoma in renografin density gradients. (1974) (21)
- A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma. (2002) (21)
- The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiation. (2012) (21)
- Protection by Corynebacterium parvum against tumour cells injected intravenously. (1972) (20)
- In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients. (1977) (19)
- Improvement in therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus misonidazole. (1991) (19)
- Potentiation of radioresponse by polymer-drug conjugates. (2001) (19)
- Leech salivary gland extract from Haementeria officinalis, a potent inhibitor of cyclophosphamide- and radiation-induced artificial metastasis enhancement. (1984) (18)
- Radioprotection of mouse jejunum by WR-2721 and WR-1065: effects on DNA strand-break induction and rejoining. (1988) (18)
- Spleen colony-forming capacity of bone marrow from mice bearing fibrosarcoma. (1971) (18)
- Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide. (1983) (17)
- Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range. (1984) (17)
- Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed. (2009) (17)
- Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. (2001) (17)
- Modification of radiation response : cytokines, growth factors, and other biological targets (2003) (17)
- Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer. (2003) (17)
- Modification of radiation-induced carcinogenesis in mice by misonidazole and WR-2721. (1992) (17)
- Antitumour effects of indomethacin alone and in combination with radiotherapy: role of inhibition of tumour angiogenesis. (1991) (17)
- Multiple phenotypic divergence of mammary adenocarcinoma cell clones. (1984) (17)
- Effects of gamma irradiation on cultured rat and mouse microvessel endothelial cells: metastatic tumor cell adhesion, subendothelial matrix degradation, and secretion of tumor cell growth factors (1991) (16)
- Apoptosis in tumor biology and therapy. (1997) (16)
- Enhancement of artificial lung metastases in mice caused by cyclophosphamide (1979) (16)
- Modification by dexamethasone of radiation response of in vitro cultured cells. (1984) (15)
- Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine. (1996) (15)
- Modification of tumor and normal tissue radioresponse in mice by N-methylformamide. (1987) (15)
- Chemopreventive doses of amifostine confer no cytoprotection to tumor nodules growing in the lungs of mice treated with cyclophosphamide. (1999) (15)
- Treatment with cortisone plus heparin or hexuronyl hexoaminoglycan sulfates of murine tumors and their lung deposits (1985) (15)
- Combining molecular therapeutics with radiotherapy for head and neck cancer (2008) (14)
- Effect of the radiosensitizer misonidazole and the radioprotector diethyldithiocarbamate on spontaneous metastasis formation of murine tumors. (1986) (14)
- WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment (2001) (14)
- Role of Epidermal Growth Factor Receptor and Its Inhibition in Radiotherapy (2003) (13)
- Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein. (1999) (13)
- Preoperative chemoradiation for locally advanced rectal cancer: emerging treatment strategies. (2002) (13)
- Protection by WR-2721 against radiation plus cis-diamminedichloroplatinum II caused injury to colonic epithelium in mice. (1994) (13)
- Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance. (1984) (13)
- Docetaxel/radiation combinations: rationale and preclinical findings. (2002) (13)
- Low E-cadherin and β-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas (1999) (13)
- Response of fibrosarcoma cell subpopulations to small doses of radiation delivered in situ. (1983) (13)
- Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2. (1981) (12)
- Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-α-aminobutyryl-D-isoglutamine (1984) (12)
- Breast Cancer Research and Treatment 2001 Reviewers (2004) (12)
- Radioprotection of cultured Chinese hamster ovary cells by WR-255591. (1988) (12)
- Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing. (1989) (12)
- Radioprotective action of aminothiols in vitro and in vivo: comparison between effects on DNA damage and cell survival. (1988) (12)
- [Inhibition of tumor neo-angiogenesis and induction of apoptosis as properties of docetaxel (taxotere)]. (1999) (12)
- A role for T lymphocytes in tumour inhibition and enhancement caused by systemic administration of Corynebacterium parvum. (1978) (12)
- The role of radiation therapy in the curative treatment of metastatic disease. (1983) (11)
- Concomitant immunity to pulmonary metastases of a murine fibrosarcoma: influence of removal of primary tumor by radiation or surgery, of active specific immunization and treatment with Corynebacterium granulosum. (1976) (11)
- Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials. (2009) (11)
- Nonspecific immunotherapy of malignant tumors. (1976) (11)
- N-methylformamide-mediated enhancement of in vitro tumor cell chemosensitivity (2004) (11)
- Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer (2011) (10)
- Polarographic pO2 measurement in mice: Effect of tumor type, site of implantation, and anesthesia (1996) (10)
- Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice. (2002) (10)
- DNA damage produced by combined hyperglycemia and hyperthermia in two mouse fibrosarcoma tumors in vivo. (1984) (10)
- Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage. (1989) (9)
- Tissue repair and repopulation in the tumor bed effect. (1988) (9)
- Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel (1999) (9)
- 16 Intratumoral microvascular density using factor 8 and CDK31 correlates with outcome for squamous cell carcinoma but not adenocarcinoma of the lung (1999) (9)
- Modification of Radiation Response (2003) (9)
- Apoptosis In Vivo (2011) (8)
- The Effect of Paclitaxel on the Cell Cycle Kinetics of a Murine Mammary Adenocarcinoma In Vivo (1997) (8)
- Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide (2007) (8)
- Predicting Radiosensitivity Using DNA End-Binding Complex Analysis (2004) (8)
- Poly (ADP-ribose) Polymerase Inhibitors in Cancer Treatment (2014) (8)
- 144 CpG oligodeoxynucleotides (CpG ODNS) are potent enhancers of radio- and chemoresponses of murine tumors (2006) (8)
- Epidermal growth factor receptor as a target to improve treatment of lung cancer. (2004) (8)
- Polymeric retinoid prodrug PG-4HPR enhances the radiation response of lung cancer. (2007) (8)
- Uncertainties in physical and biological targeting with radiation therapy. (2003) (8)
- Enhancement of radiation-induced normal tissue damage by a fibrosarcoma. (1987) (7)
- Radiation-induced apoptosis in tumors: effect of radiation modulating agents. (1997) (7)
- The effects of N-methylformamide on artificial and spontaneous metastases from a murine hepatocarcinoma. (1987) (7)
- Antitumor and antimeta static activity of the differentiating agent N-methylformamide in murine tumor systems (1987) (7)
- Inhibition of P-TEFb by DRB suppresses SIRT1/CK2α pathway and enhances radiosensitivity of human cancer cells. (2014) (7)
- Need for studies on factors that influence radioprotection of solid tumors by WR-2721. (1984) (7)
- Role of Cyclooxygenase-2 (COX-2) and Its Inhibition in Tumor Biology and Radiotherapy (2003) (7)
- Proliferation kinetics of a murine fibrosarcoma during fractionated irradiation. (1988) (7)
- Improvement in radiotherapy for a murine sarcoma by indomethacin plus WR-2721. (1993) (7)
- Combined IFN-γ–Endostatin Gene Therapy and Radiotherapy Attenuates Primary Breast Tumor Growth and Lung Metastases via Enhanced CTL and NK Cell Activation and Attenuated Tumor Angiogenesis in a Murine Model (2009) (6)
- Increase in radiosensitivity of lung micrometastases by hyperbaric oxygen (2005) (6)
- Metastatic instability of murine tumor metastases: Dependence on tumor type (1988) (6)
- Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice. (1974) (6)
- The effect of dose modifiers on radiation response of resected tumors (1989) (6)
- Phase I clinical trial using selective cyclooxygenase-2 (COX-2) inhibitor celecoxib with concurrent thoracic irradiation in patients with poor prognosis non-small cell lung cancer (NSCLC) (2004) (5)
- Effects of whole body irradiation in mice treated with C. parvum. (1979) (5)
- Therapy of spontaneous pulmonary metastases of a murine mammary carcinoma with anaerobic corynebacteria (2004) (5)
- Proliferation kinetics of recruited cells in a mouse mammary carcinoma. (1994) (5)
- Concomitant development of granulocytosis and enhancement of metastases formation in tumor-bearing mice (1984) (5)
- Prolonged survival of skin allografts from tumour-bearing mice. (1972) (4)
- Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study. (2009) (4)
- Enhancement ofin vitro chemotherapeutic activity by dimethylsulfoxide (1985) (4)
- Protection of cultured Chinese hamster ovary cells by the aminothiol WR-255591 from the lethal and DNA-damaging effects of fast neutrons. (1989) (4)
- Enhancement by misonidazole of metastatic tumor nodule formation in the lungs of mice (2004) (4)
- A role for T lymphocytes in the antitumour action of systemic C. parvum. (1977) (4)
- Determinants of tumor chemo-radioresistance (2005) (4)
- Stimulation of hematopoietic cell recovery by tetrachlorodecaoxide in sublethally irradiated mice. (1993) (4)
- Assessment of antitumor (antimetastatic) efficacy of cytotoxic agents. (1986) (3)
- Combination of interleukin-2 and irradiation in therapy of murine tumors (1992) (3)
- The effect of dexamethasone on the radiation sensitivity of cultured cells. (1983) (3)
- Adoptive immunotherapy as an adjunctive treatment to thoracic irradiation for pulmonary tumor deposits in mice. (1989) (3)
- Activation of pleural macrophages by intrapleural application of Corynebacterium parvum. (1979) (3)
- Effect of tumor cell culture media and sera from tumor hosts on spreading, phagocytosis, and antitumor cytotoxicity of C. parvum-activated murine macrophages (1979) (3)
- Translational Research Program (2001) (3)
- Cytotoxic treatments and tumor oxygenation. (1996) (3)
- Assessment of resistance to paclitaxel of murine tumors by (99m)Tc-MIBI/(201)Tl dual-radionuclide imaging. (2000) (3)
- Effects of C. parvum on radiation response of murine tumors. (1977) (3)
- Cisplatin‐induced enhancement of radioresponse in a murine mammary carcinoma: Test of a role for apoptosis (1995) (3)
- Influence of Splenectomy upon Immunologic Reactivity of Patients with Hodgkin'S Disease (1981) (3)
- An improved technic for skin grafting in mice. (1970) (3)
- Enhancement of lung colony formation by admixing irradiated with viable tumor cells: dependence on host status (1987) (3)
- ANAEROBIC CORYNEBACTERIA AND ANÆSTHETICS (1975) (3)
- Hyperfractionated and accelerated thoracic radiation therapy (HFXATRT) increased survival compared to daily TRT (QDTRT) for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy (2004) (3)
- Epidermal Growth Factor and Its Receptor in Tumor Response to Radiation (2000) (3)
- Molecular Mechanisms of Radiotherapy (2005) (3)
- INTEGRATING RADIOTHERAPY WITH EGFR ANTAGONISTS AND OTHER MOLECULAR THERAPEUTICS FOR THE TREATMENT OF HEAD AND NECK CANCER (2007) (2)
- Antitumor activity of pyrimidinone interferon inducers. Abstr. (1981) (2)
- COX-2 inhibitor enhances tumor radioresponse in vitro and in vivo (1999) (2)
- WR-2721 Reduces Intestinal Toxicity from Concurrent Gemcitabine and Radiation Treatment. (2001) (2)
- On the α/β ratio and oer for clonogenic tumor cells (1985) (2)
- Radioprotectors and Chemoprotectors in the Management of Lung Cancer (2011) (2)
- In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with C. parvum. (1977) (2)
- [Recent studies on anti-angiogenesis in cancer therapy]. (2000) (2)
- Studies on the antitumor activities of pyrimidinone-interferon inducers. Part 2 Potentiation of antitumor resistance mechanisms (1983) (2)
- Tumor metastasis: achievements, dilemmas, and future, a summary of the conference. (1983) (2)
- Increased sensitivity of C. parvum treated mice to ionizing whole body irradiation. (1977) (2)
- Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. (2005) (2)
- In vitro destruction of tumor cells by corynebacterium granulosum (cg) activated macrophages. Abstr. (1975) (1)
- Prognostic significance of COX-2 expression in advanced head and neck cancer treated with radiotherapy in a phase III RTOG trial (90-03) (2001) (1)
- Cyclooxygenase-2 Inhibitor Preferential Enhancement of Tumor Radioresponse by a Updated (2000) (1)
- Antimetastatic Effects of Intrapleurally Injected Corynebacterium Parvum (1980) (1)
- Repression of transcription via cyclin-dependent kinase-9 inhibition is associated with flavopiridol - induced enhancement of radiosensitivity of human esophageal adenocarcinoma cells (2006) (1)
- CpG oligodeoxynucleotide (ODN) is a potent enhancer of fractionated radiotherapy. (2004) (1)
- WR-2721 protects antitumor immune resistance against damage by whole body irradiation (WBI) and cyclophosphamide (CY) (1984) (1)
- Cyclo-Oxygenase-2 Enzyme and Its Inhibition in Tumor Growth and Therapy (2005) (1)
- Inverse Relationship between Epidermal Growth Factor Receptor Expression and Radiocurability of Murine Carcinomas 1 (1999) (1)
- Failure to observe 'skin heterogenization' in mice. (1970) (1)
- Phase III trial of amifostine with chemoradiation for inoperable non-small cell lung cancer (NSCLC): does amifostine protect cancer cells (2002) (1)
- Impact of EGFR expression on the response of advanced head and neck carcinomas to concomitant boost radiotherapy in a RTOG phase III trial (90-03) (2003) (1)
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program. (2001) (1)
- Influence of tumor bed stroma damage on tumor radio- and chemoresponse (1984) (1)
- DNA cross-linking following exposure to cis-platinum in primary and serially passaged cultured cells derived from two murine fibrosarcomas (2004) (1)
- The Role of Modification of DNA Damage in the Radioprotective Action of Aminothiols (1987) (1)
- Enhancement of Pulmonary Metastases Induced in Mice by Cyclophosphamide: Role of the Immune System (1980) (1)
- Effects of size and growth time of a murine sarcoma on its metastatic spread (2004) (1)
- Abstract 369: Treatment with vandetanib can overcome resistance of head and neck squamous cell carcinoma cells to cisplatin and radiation in an orthotopic animal model (2010) (1)
- Preclinical in vivo evaluation of a novel treatment strategy combining a Wee1 inhibitor with radiotherapy. (2010) (1)
- P29 15 WP – RADIOPROTECTION AND ANTITUMOR ACTIVITY OF TCDO IN MICE (1991) (1)
- The effect of N-methylformamide on radiocurability of murine tumors. (1988) (1)
- Apoptosis and inhibition of neoangiogenesis as mechanisms of antitumor action by docetaxel (Taxotere) (2000) (1)
- CpG Oligodeoxynucleotides (CpG ODN) Immunotherapy Enhances Tumor Radioresponse: Systemic Effects and Mechanisms (2008) (1)
- Tumor Metastasis: Biology and Experimental Therapeutic Approaches (1987) (1)
- In vivo radioprotection of normal tissues and a tumor by diethyldithiocarbamate (DDC) (1984) (1)
- Metastatic abilities of murine sarcomas and carcinomas. II. Relationship to cell volume and DNA index (1990) (1)
- Single Nucleotide Polymorphism at rs1982073:T869C of the TGF (cid:1) 1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non–Small-Cell Lung Cancer Treated With Definitive Radiotherapy (2009) (1)
- Abstract 5674: Huachansu, an extract from toad skin, strongly enhances radiosensitivity of human lung cancer cell lines (2010) (1)
- Effect of tumor size in tumor radioprotective effects of wr2721. Abstr. (1982) (1)
- Inhibition of DNA-end binding complex formation as a mechanism for celecoxib-induced radioenhancement in human head and neck carcinoma cells (2004) (1)
- 152 Improvement of esophageal adenocarcinoma cell and xenograft responses to chemoradiation by targeting cyclin-dependent kinases (2006) (1)
- Tumor bed irradiation enhances sensitivity of A431 tumor xenografts to C225 anti-EGFR antibody (2008) (1)
- Abstract 1161: Visualizing lung cancer heterogeneity by color-coding clonal cell subpopulations (2010) (1)
- WR-2721 protects against cytoxan-induced hprt mutagenesis without affecting therapeutic effectiveness (1995) (1)
- [Combination of chemotherapy and immunotherapy in the treatment of carcinoma of the mammary gland in mice (author's transl)]. (1978) (0)
- Abstract 2487: A multi-kinase inhibitor, XL228, enhanced human cancer cell radiosensitivity and suppressed cell invasion and migration (2011) (0)
- Fractionated Radiotherapy Oligodeoxynucleotides Enhances Tumor Response to Targeting Toll-like Receptor 9 with CpG (2004) (0)
- Role of cyclin D1 in tumor radioresponse (2000) (0)
- Corynebacterium granulosum-Induced Prophylaxis and Therapy of Artificial Pulmonary Metastases of Syngenic Murine Tumors (1975) (0)
- Maturational agents alone or in combination with cytotoxic agents in therapy of tumor metastases. (1988) (0)
- Abstract #5602: Inhibition of RNA polymerase II activity enhances radiosensitivity of human non_small cell lung carcinoma in vitro (2009) (0)
- Chapter 5 – Principles of Combining Radiation Therapy and Molecular Therapeutics (2010) (0)
- 414 Interactions of radiation with novel chemotherapeutic agents: Taxanes and nucleoside analogs (1997) (0)
- Abstract 488: cSrc is a radioresistance molecule in cancer radiotherapy: cSrc-siRNA transfection augments tumor cell radiosensitivity in vitro and chemical inhibition of Src kinases increases tumor response to radiation (2010) (0)
- [Tumor immunology]. (1970) (0)
- [Macrophage as a participant in resistance against malignant tumor]. (1977) (0)
- Molecular Biology of Lung Cancer (2006) (0)
- Abstract 2507: Triple agent therapy combining radiation with AMG479 (IGF1R antibody) and panitumumab (EGFR antibody) in a head and neck tumor model (2011) (0)
- Nano Sponges for Drug Delivery and Medicinal Applications (2012) (0)
- 115 Apoptosis and mitosis as prognostic factors in 173 patients with pathologically staged N1 nonsmall cell lung cancer (NSCLC) (1995) (0)
- Effect of taxol alone and in combination with radiation on the gastrointestinal mucosa (1994) (0)
- Clinical perspectives for the treatment of metastases (1989) (0)
- Abstract 2488: Co-targeting EGFR and IGF-1R to sensitize or overcome induced resistance of head and neck cancer models to radiation (2011) (0)
- [Do viruses cause tumors in human beings?]. (1971) (0)
- The effect of combination of radiation with bleomycin (blm) and cis-platinum (cis-ddp) on colon crypt cells and protection against damage by wr2721. Abstr. (1982) (0)
- 351 POSTER Identification of kinases that are potential molecular determinants of cellular response to radiation using antibody arrays (2008) (0)
- 584 Enhancement of radioresponse of murine tumors by paclitaxel (PAX) or taxotere (TAX) (1997) (0)
- Transfer of primary immune response by foreign immune cells. Abstr. (1969) (0)
- Early Detection of Chemoradiotherapy Response in Esophageal Carcinoma by Fluorothymidine (FLT) PET Imaging (2005) (0)
- 2659 : Inhibition of VEGFR-1, -2, and -3 Signaling by AZD2171 Enhances the Anti-Tumor Efficacy of Radiation Therapy in a Mouse Xenograft Model (2006) (0)
- Corynebacterium parvum: Effect on radiocurability of murine tumors (1978) (0)
- Association of activated transcription factor NF-kappaB with chemo-radiotherapy resistance and poor outcome in esophageal adenocarcinoma (2005) (0)
- Cory neb acterium granulosum-ináuced Protection against Artificial Pulmonary Métastasesof a Syngeneic Fibrosarcoma in Mice1 (2006) (0)
- Plans for ISGIO's Fourth Annual GI Oncology Conference Under Way (2007) (0)
- Immunological Resistance to Pulmonary Mà © tastases ¡ n C 3 Hf / Bu Mice Bearing Syngeneic Fibrosarcoma of Different Sizes 1 (2006) (0)
- マウス乳癌における、TaxolによるMitosis、Apoptosis、p53蛋白の誘導 (1998) (0)
- Late abstracts 186–187 (2005) (0)
- E16 - Integration of molecular targeting with radiotherapy: Recent achievements and improvement strategies (2007) (0)
- containing radiation therapy and a COX-2 inhibitor in the treatment of neoplasia (1999) (0)
- ABI-007, nanoparticle albumin-bound paclitaxel, enhances tumor radioresponse. (2006) (0)
- Surgery, Radiotherapy, Chemotherapy, Hormonal Therapy (1989) (0)
- Letter: Anaerobic corynebacteria and anaesthetics. (1975) (0)
- Corrigendum to “Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 non small cell lung cancer (NSCLC)” [Lung Cancer 18 (S1) (1997) 160] (2013) (0)
- Effects of Radiotherapy and Chemotherapy on Tumor Bed Stroma1 (1988) (0)
- The effect of misonidazole and fractionated low doses of radiation on selected tumor subpopulations in vivo. Abstr. (1982) (0)
- Effect of oxygen on in vitro tumour cell growth and interaction of macrophages and tumour cells (1985) (0)
- Abstract 2509: Preclinical evaluation of the effects of cilengitide, an inhibitor of integrins, in sensitizing human solid cancer xenografts to radiation (2011) (0)
- Metastasis: Growth and Pathogenesis, Models, and Mechanisms (1989) (0)
- Combinations of Taxanes and Ionizing Radiation (2006) (0)
- Abstract 1461: MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation (2012) (0)
- P-959 A dose escalation clinical trial using thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer (NSCLC) (2005) (0)
- Esophageal Adenocarcinoma: Treatment: Chemotherapy for metastatic cancer of the esophagus, gastroesophageal junction, and stomach (2009) (0)
- 311 TUMOR MICROENVIRONMENT AND INTEGRINS AS EFFECTIVE THERAPEUTIC TARGETS TO IMPROVE RADIOTHERAPY OUTCOME (2012) (0)
- P29 03 WP – INCREASED TUMOR CELL TAKE AND PROLIFERATION RATE IN CY-TREATED MICE (1991) (0)
- Effect of c. Parvum (cp) on he@@@@matopoietic activity survival of whole body irradiated (wbi) mice. Abstr. (1977) (0)
- Normal tissue antigens of tumor cells. (1969) (0)
- [Radiation therapy and metastasis--biologic and therapeutic aspects]. (1984) (0)
- Single Nucleotide Polymorphism of the TGF-B1 T869C Gene Associates Risks of Treatment Related Pneumonitis and Distant Metastasis in Patients with Non–small-cell Lung Cancer Treated with Definitive Radiotherapy (2009) (0)
- Potentiation of Tumor Radioresponse by Combination of Indomethacin with the Hypoxic Cell Radiosensitizer Misonidazole (1993) (0)
- Protection against radiation-induced enhancement of tumor metastases in lung of mice by treatment with c. Granulosum. Abstr. (1974) (0)
- Apoptosis : basic biology and relationship to cancer (2002) (0)
- P16 30 MP – TEMPORAL AND DOSE RESPONSES OF APOPTOSIS IN RADIOSENSITIVE AND RADIORESISTANT MURINE TUMORS (1991) (0)
- Role of epidermal growth factor receptor and its blockade in tumor radioresponse (2000) (0)
- A pan Her inhibitor, BMS-599626, augments radiosensitivity of HN5 cells by increasing radiation-induced apoptosis and inhibiting DNA repair. (2007) (0)
- Effects of radiotherapy and chemotherapy on tumor bed stroma. (1989) (0)
- C. Granulosum (cg) - and c. Parvum (cp)-induced augementation of the radiocurability of a murine fibrosarcoma (fsa). Abstr. (1975) (0)
- Abstract A145: EGFR-targeting of carbon nanovectors loaded with paclitaxel improves their antitumor efficacy and radiosensitization of head and neck squamous cell carcinoma in vivo. (2011) (0)
- Heterogeneous Response and Clonal Drift of Sensitivities of Metastatic 13762NF Mammary Adenocarcinoma Clones to y-Radiation in Wfro1 (2006) (0)
- 272The role of apoptosis in tumor response to radiation (1996) (0)
- Adoptive Immunotherapy as an Adjunct!vc Treatment to Thoracic Irradiation for Pulmonary Tumor Deposits in Mice1 (2006) (0)
- [Serum immune complexes in patients with tumors (author's transl)]. (1980) (0)
- [Immunological cell-type reaction in patients with and without malignant tumors]. (1973) (0)
- Konbinationsterapi of irradiation and a COX-2 inhibitor for treatment of neoplasia (1999) (0)
- Molecular targeting of toll-like receptor 9 with CpG oligodeoxynucleotides (ODN) for enhancement of tumor radioresponse (2004) (0)
- Association between Treatment-related Pneumonitis and the Overall Survival after Definitive Radiotherapy for Non–small Cell Lung Cancer (2009) (0)
- [Multicellular tumor spheroids: a suitable model for tumor biology studies in vitro (author's transl)]. (1980) (0)
- Antitumor activity of Corynebacterium parvum administered into the pleural cavity of mice (1979) (0)
- 624 Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 nonsmall cell lung cancer (NSCLC) (1997) (0)
- Strong enhancement of tumor radioresponse by CpG oligodeoxynucleotide (ODN) (2004) (0)
- Cancer Therapy : Preclinical Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells ’ Sensitivity to Cisplatin and Radiation In Vivo and In Vitro (2011) (0)
- Therapy with corynebacterium parvum (cp) of spontaneous pulmonary metastases of a murine mammary carcinoma. Abstr. (1976) (0)
- Inhibition of Prostaglandin Production in Malignant Tumors: Implications to Radiotherapy (1991) (0)
- Delayed cutaneous hypersensitivity reaction to tumor-specific antigens of fibrosarcoma in sensitized mice (1970) (0)
- P29 14 WP – COMBINATION OF INTERLEUKIN-2 AND IRRADIATION IN THERAPY OF MURINE TUMORS (1991) (0)
- 1 Improvement of radio(chemo)therapy by molecular-targeting approaches: Focus on cancer cell clonogens (CCCS) (2006) (0)
- Enhancement of metastasis formation concomitant with granulocytosis in tumor-bearing mice. Abstr. (1983) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lukas Milas?
Lukas Milas is affiliated with the following schools:
